Authors:
OR R
ACKERSTEIN A
NAGLER A
KAPELUSHNIK J
NAPARSTEK E
SAMUEL S
AMAR A
BRUATBAR C
SLAVIN S
Citation: R. Or et al., ALLOGENEIC CELL-MEDIATED IMMUNOTHERAPY FOR BREAST-CANCER AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION - A CLINICAL PILOT-STUDY, Cytokines cellular & molecular therapy, 4(1), 1998, pp. 1-6
Authors:
OR R
ACKERSTEIN A
NAGLER A
AMAR A
NAPARSTEK E
VARADI G
KAPELUSHNIK J
SAMUEL S
PUGATSCH T
BRAUTBAR C
SLAVIN S
Citation: R. Or et al., ALLOGENEIC CELL-MEDIATED AND CYTOKINE-ACTIVATED IMMUNOTHERAPY FOR MALIGNANT-LYMPHOMA AT THE STAGE OF MINIMAL RESIDUAL DISEASE AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION, Journal of immunotherapy, 21(6), 1998, pp. 447-453
Citation: T. Hahn et al., HUMAN BONE-MARROW-DERIVED MITOGENIC STIMULATION SELECTIVE FOR BONE-MARROW METASTATIC TUMOR-CELLS, European cytokine network, 9(3), 1998, pp. 265-265
Authors:
AKER M
KAPELUSHNIK J
PUGATSCH T
NAPARSTEK E
BENNERIA S
YEHUDA O
AMAR A
NAGLER A
SLAVIN S
OR R
Citation: M. Aker et al., DONOR LYMPHOCYTE INFUSIONS TO DISPLACE RESIDUAL HOST HEMATOPOIETIC-CELLS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR BETA-THALASSEMIA MAJOR, Journal of pediatric hematology/oncology, 20(2), 1998, pp. 145-148
Authors:
NAPARSTEK E
NAGLER A
OR R
VARADI G
BENYOSEF R
ACKERSTEIN A
SLAVIN S
Citation: E. Naparstek et al., POST TRANSPLANT IMMUNOTHERAPY FOR PREVENTION OF RELAPSE AFTER AUTOLOGOUS BMT FOR ACUTE-LEUKEMIA, Experimental hematology, 26(8), 1998, pp. 353-353
Authors:
SLAVIN S
NAGLER A
NAPARSTEK E
OR R
VARADI G
BENYOSEF R
HUSSIEN A
AKER M
CIVIDALLI G
Citation: S. Slavin et al., LEUKEMIA IMMUNOTHERAPY IN CONJUNCTION WITH NON MYELOABLATIVE ALLOGENEIC STEM-CELL TRANSPLANTATION, Experimental hematology, 26(8), 1998, pp. 354-354
Citation: R. Or et al., THALIDOMIDE REDUCES VASCULAR DENSITY IN GRANULATION-TISSUE OF SUBCUTANEOUSLY IMPLANTED POLYVINYL-ALCOHOL SPONGES IN GUINEA-PIGS, Experimental hematology, 26(3), 1998, pp. 217-221
Authors:
NAGLER A
NAPARSTEK E
OR R
VARADI G
SLAVIN S
Citation: A. Nagler et al., THIOTEPA, BUSULFAN, CYCLOPHOSPHAMIDE AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR ACUTE-LEUKEMIA, Bone marrow transplantation, 21, 1998, pp. 343-343
Authors:
ENGELHARD D
OR R
STRAUSS N
ELISHOOV H
NAPARSTEK E
AKER M
CIVIDALLI G
NAGLER A
KAPELUSHNIK Y
SIMHON A
SHAPIRO M
MAAYAN S
RAHAV G
MOSES AE
SLAVIN S
Citation: D. Engelhard et al., RISK-FACTORS FOR NOSOCOMIAL SEPTICEMIA FOLLOWING BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 506-506
Authors:
ACKERSTEIN A
NAGLER A
NAPARSTEK E
KAPELUSHNIK J
VARADI G
SLAVIN S
OR R
Citation: A. Ackerstein et al., LONG-TERM IMMUNOTHERAPY WITH INTERFERON-ALPHA (IFN-ALPHA)FOR MULTIPLE-MYELOMA PATIENTS FOLLOWING AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT), Bone marrow transplantation, 21, 1998, pp. 708-708
Authors:
NAGLER A
KAPELUSHNIK I
AKER M
OR R
SLAVIN S
Citation: A. Nagler et al., ALLOGENEIC BONE-MARROW AND CORD-BLOOD TRANSPLANTATIONS FOR FANCONIS-ANEMIA (FA) USING A NOVEL CONDITIONING REGIMEN WITH NO IRRADIATION, Bone marrow transplantation, 21, 1998, pp. 785-785
Citation: R. Sassan et al., EFFECT OF THE CONDITIONING REGIMEN ON ANTIOXIDANT CAPACITY IN THE PLASMA OF MARROW TRANSPLANTED PATIENTS, Bone marrow transplantation, 21, 1998, pp. 954-954
Citation: A. Nagler et al., ENGRAFTMENT FOLLOWING MITOXANTRONE (MITO) BASED CONDITIONING FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO-BMT), Leukemia research, 22(3), 1998, pp. 209-213
Authors:
NAGLER A
FINLANDER R
OR R
NAPARSTEK E
VARADI G
SLAVIN S
Citation: A. Nagler et al., THE ROLE OF THIOTEPA IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE-LEUKEMIA, Leukemia research, 22(11), 1998, pp. 991-995
Citation: H. Elishoov et al., NOSOCOMIAL COLONIZATION, SEPTICEMIA, AND HICKMAN BROVIAC CATHETER-RELATED INFECTIONS IN BONE-MARROW TRANSPLANT RECIPIENTS - A 5-YEAR PROSPECTIVE-STUDY/, Medicine, 77(2), 1998, pp. 83-101
Citation: T. Hahn et al., HUMAN BONE-MARROW-DERIVED MITOGENIC STIMULATION SELECTIVE FOR BREAST-CARCINOMA AND NEUROBLASTOMA-CELLS, International journal of cancer, 78(5), 1998, pp. 624-628
Citation: R. Or et al., FLUDARABINE MONOPHOSPHATE AS THERAPY FOR MURINE LEUKEMIA MODIFIES GRAFT-VERSUS-HOST DISEASE (GVHD) WITHOUT DECREASING THE GRAFT-VERSUS-LEUKEMIA (GVL) EFFECT, British Journal of Haematology, 102(1), 1998, pp. 64-64
Authors:
SLAVIN S
NAGLER A
NAPARSTEK E
KAPELUSHNIK Y
AKER M
CIVIDALLI G
VARADI G
KIRSCHBAUM M
ACKERSTEIN A
SAMUEL S
AMAR A
BRAUTBAR C
BENTAL O
ELDOR A
OR R
Citation: S. Slavin et al., NONMYELOABLATIVE STEM-CELL TRANSPLANTATION AND CELL THERAPY AS AN ALTERNATIVE TO CONVENTIONAL BONE-MARROW TRANSPLANTATION WITH LETHAL CYTOREDUCTION FOR THE TREATMENT OF MALIGNANT AND NONMALIGNANT HEMATOLOGIC DISEASES, Blood, 91(3), 1998, pp. 756-763
Authors:
GILON D
SCHECHTER D
REIN AJJT
GIMMON Z
OR R
ROZENMAN Y
SLAVIN S
GOTSMAN MS
NAGLER A
Citation: D. Gilon et al., RIGHT ATRIAL THROMBI ARE RELATED TO INDWELLING CENTRAL VENOUS CATHETER POSITION - INSIGHTS INTO TIME-COURSE AND POSSIBLE MECHANISM OF FORMATION, The American heart journal, 135(3), 1998, pp. 457-462
Authors:
NAGLER A
ACKERSTEIN A
BENSHAHAR M
OR R
NAPARSTEK E
BENYOSEF R
SLAVIN S
Citation: A. Nagler et al., CONTINUOUS INTERLEUKIN-2 INFUSION COMBINED WITH CYCLOPHOSPHAMIDE-BASED COMBINATION CHEMOTHERAPY IN THE TREATMENT OF HEMATO-ONCOLOGICAL MALIGNANCIES - RESULTS OF A PHASE I-II STUDY, Acta haematologica, 100(2), 1998, pp. 63-68
Authors:
TOREN A
ILAN Y
OR R
KAPELUSHNIK J
NAGLER A
Citation: A. Toren et al., IMPAIRED LIVER-FUNCTION TESTS IN PATIENTS TREATED WITH ANTITHYMOCYTE GLOBULIN - IMPLICATION FOR LIVER-TRANSPLANTATION, Medical oncology, 14(3-4), 1997, pp. 125-129